Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH ‐mutant and 1p/19q codeleted: A French POLA network study
Cancer · 2025
DOI: 10.1002/cncr.35814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2025. Verfasst von Alexandre Bertucci und 22 weiteren Autor:innen. Beteiligte Einrichtung: Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France. Hauptthemen laut MEDLINE: Oligodendroglioma, Brain Neoplasms, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French Institut National du Cancer.
Abstract (Originalsprache)
Background
Brain tumors represent one of the main causes of cancer‐related mortality in young patients. Among them, oligodendrogliomas (OG) are adult‐type diffuse gliomas with the best prognosis. Nevertheless, characterization of these tumors in the young population remains poorly documented. Our objective was to characterize the population of young adults under 40 years of age with grade 3 OG in the POLA cohort.
Methods
Clinical data prospectively collected for all patients registered with grade 3 OG between April 2009 and August 2021 were extracted from the national POLA database. This study compared the patient subgroup 40 years of age.
Results
The authors included 111 patients
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.
- APHM, CHU Timone, Service de Neurooncologie, Marseille, France.
- APHM, CHU Timone, Service d'Anatomopathologie, Marseille, France.
- Hospices Civils de Lyon, Hôpital Neurologique, Neuro-oncology Department, Department of Cancer Cell Plasticity, Cancer Research Center of Lyon, Claude Bernard University, Lyon, France.
- Medical Oncology Department, CHU de Bordeaux, Bordeaux, France.
- Neurosurgery Department, CHU de Lille, Lille, France.
ORCID-Profile: Alexandre Bertucci
Förderung
- French Institut National du Cancer
Zitieren
APA
Bertucci, A., Dufour, O., Appay, R., Harlay, V., Ducray, F., Bronnimann, C., Djelad, A., Cohen-Jonathan Moyal, E., Campone, M., Langlois, O., Ducloie, M., Vauleon, E., Younan, N., Desenclos, C., Ramirez, C., Touat, M., Idbaih, A., Bequet, C., Figarella-Branger, D., …, & POLA network (2025). Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH ‐mutant and 1p/19q codeleted: A French POLA network study. Cancer. https://doi.org/10.1002/cncr.35814
Vancouver
Bertucci A, Dufour O, Appay R, Harlay V, Ducray F, Bronnimann C, et al. Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH ‐mutant and 1p/19q codeleted: A French POLA network study. Cancer. 2025. doi:10.1002/cncr.35814
BibTeX
@article{Bertucci2025,
author = {Bertucci, Alexandre and Dufour, Ondine and Appay, Romain and Harlay, Vincent and Ducray, François and Bronnimann, Charlotte and Djelad, Apolline and Cohen-Jonathan Moyal, Elisabeth and Campone, Mario and Langlois, Olivier and Ducloie, Mathilde and Vauleon, Elodie and Younan, Nadia and Desenclos, Christine and Ramirez, Carole and Touat, Mehdi and Idbaih, Ahmed and Bequet, Céline and Figarella-Branger, Dominique and Dehais, Caroline and Chinot, Olivier and Tabouret, Emeline and POLA network, POLA network},
title = {Characteristics, outcome, and prognostic factors of young patients with central nervous system World Health Organization grade 3 oligodendrogliomas IDH ‐mutant and 1p/19q codeleted: A French POLA network study},
journal = {Cancer},
year = {2025},
doi = {10.1002/cncr.35814}
}
EUVIMED